Bioresorbable scaffolds represent a novel option for treatment of below-the-knee lesions that offer advantages over permanent devices. New data show not only efficacy and safety parity with angioplasty balloon angioplasty, but LIFE-BTK also demonstrated that scaffolds lower BTK limb events.
In this 1-hour webinar, LIFE-BTK trial leaders, a representative from the FDA, and a wound care expert shared their perspectives on the trial, its design, and the ramifications of its findings.
Funded by Abbott
Co-Moderators
Ehrin Armstrong, MD; Niten Singh, MD
Speakers & panel
Brian DeRubertis, MD; Elizabeth Genovese, MD; Raghu Kolluri, MD, MS; Misti Malone, PhD; Sahil A. Parikh, MD; Mahmood Razavi, MD;
Ramon Varcoe, MBBS, MS, PhD
